Related Experiment Video
Updated: Jun 2, 2026

07:08
A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status
Published on: October 20, 2016
Longitudinal change in CSF biomarkers in a presymptomatic carrier of an APP mutation
J M Ringman1, K Taylor, E Teng
1Easton Center for Alzheimer's Disease Research, UCLA Department of Neurology, Los Angeles, CA 90095-7226, USA jringman@mednet.ucla.edu
Neurology
|May 13, 2011
Abstract
No abstract available in PubMed .

